is glp-1 covered by medicaid Which Weight Loss Meds Are Medicaid? The 2026 State-by-State Breakdown Pennsylvania restricts Medicaid coverage for
Description
Current FDA labels document these patterns in detail: Wegovy (semaglutide) lists nausea (44% vs 16% placebo), vomiting (25% vs 6%), diarrhea (30% vs 16%), constipation (24% vs 11%), abdominal distension and eructation, with severe GI events in 4.1% versus 0.9% placebo.[2] Zepbound (tirzepatide) lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, eructation, and gastroesophageal reflux disease among common adverse reactions, with severe GI disease as a Warnings and Precautions item.[3] Both labels include postmarketing reports of ileus, severe constipation including fecal impaction, and acute kidney injury related to dehydration from severe GI symptoms

And theres no sign of it slowing down

The discovery and development of liraglutide and semaglutide
Choose lower-fat meals, especially during dose escalation periods, as fatty foods can worsen GLP-1-related digestive symptoms
